Revising the fasting glucose threshold for detection of cardiovascular risk factors: analysing two representative population-based studies of more than 50 000 Iranians in 3 years: The National Survey of Risk Factors for Non-Communicable Diseases of Iran

References

• ADA. 2003. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696
   PubMed Web of Science ®Google Scholar
• ADA. 2010. Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62–S69
   PubMed Web of Science ®Google Scholar
• Adams RJ, Appleton SL, Hill CL, Wilson DH, Taylor AW, Chittleborough CR, Gill TK, Ruffin RE. 2009. Independent association of HbA(1c) and incident cardiovascular disease in people without diabetes. Obesity (Silver Spring) 17:559–563
   PubMed Web of Science ®Google Scholar
• Anand SS, Dagenais GR, Mohan V, Diaz R, Probstfield J, Freeman R, Shaw J, et al. 2011. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Prevent Cardiol 19:755–764
   Web of Science ®Google Scholar
• Arky RA. 2005. ‘Doctor, is my sugar normal?’. N Engl J Med 353:1511–1513
   PubMed Web of Science ®Google Scholar
• Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM. 2004. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 53:2095–2100
   PubMed Web of Science ®Google Scholar
• Cederberg H, Saukkonen T, Laakso M, Jokelainen J, Harkonen P, Timonen M, Keinanen-Kiukaanniemi S, Rajala U. 2010. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 33:2077–2083
   PubMed Web of Science ®Google Scholar
• Dalleck LC, Van Guilder GP, Quinn EM, Bredle DL. 2013. Primary prevention of metabolic syndrome in the community using an evidence-based exercise program. Prev Med 57:392–395
   PubMed Web of Science ®Google Scholar
• Dallo FJ, Weller SC. 2003. Effectiveness of diabetes mellitus screening recommendations. Proc Natl Acad Sci USA 100:10574–10579
   PubMed Web of Science ®Google Scholar
• De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, et al. 2003. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 10:S1–S10
   PubMed Web of Science ®Google Scholar
• Donahue RP, Dorn JM, Stranges S, Swanson M, Hovey K, Trevisan M. 2011. Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience. Nutr Metab Cardiovasc Dis 21:504–511
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H. 2006. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovasc Diabetol 5:15
   PubMedGoogle Scholar
• Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, Safaie A, et al. 2008. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 31:96–98
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, Kamgar M, et al. 2009. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health 9:167
   PubMed Web of Science ®Google Scholar
• Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC. 2000. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23:1108–1112
   PubMed Web of Science ®Google Scholar
• Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, et al. 2003. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167
   PubMed Web of Science ®Google Scholar
• Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K. 2004. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 27:727–733
   PubMed Web of Science ®Google Scholar
• Godsland IF, Jeffs JA, Johnston DG. 2004. Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157–1166
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Tabara Y, Kusunoki T, Abe M, Kohara K, Miki T. 2013. A slightly high-normal glucose level is associated with increased arterial stiffness in Japanese community-dwelling persons with pre-diabetes. Vasc Med 18:251–256
   PubMed Web of Science ®Google Scholar
• Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N. 2001. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322:15–18
   PubMed Web of Science ®Google Scholar
• Kim HK, Kim CH, Kim EH, Bae SJ, Choe J, Park JY, Park SW, et al. 2013. Impaired fasting glucose and risk of cardiovascular disease in Korean men and women: the Korean Heart Study. Diabetes Care 36:328–335
   PubMed Web of Science ®Google Scholar
• Kim SH, Chunawala L, Linde R, Reaven GM. 2006. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice. J Am Coll Cardiol 48:293–297
   PubMed Web of Science ®Google Scholar
• Lawes CM, Parag V, Bennett DA, Suh I, Lam TH, Whitlock G, Barzi F, Woodward M. 2004. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 27:2836–2842
   PubMed Web of Science ®Google Scholar
• Levitan EB, Song Y, Ford ES, Liu S. 2004. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155
   PubMed Web of Science ®Google Scholar
• Lindstrom J, Tuomilehto J. 2003. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731
   PubMed Web of Science ®Google Scholar
• Liu J, Grundy SM, Wang W, Smith SC Jr, Vega GL, Wu Z, Zeng Z, et al. 2007. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J 153:552–558
   PubMed Web of Science ®Google Scholar
• Morrison JA, Glueck CJ, Wang P. 2012. Childhood risk factors predict cardiovascular disease, impaired fasting glucose plus type 2 diabetes mellitus, and high blood pressure 26 years later at a mean age of 38 years: the Princeton-lipid research clinics follow-up study. Metabolism 61:531–541
   PubMed Web of Science ®Google Scholar
• Pallardo LF, Herranz L, Martin-Vaquero P, Garcia-Ingelmo T, Grande C, Janez M. 2003. Impaired fasting glucose and impaired glucose tolerance in women with prior gestational diabetes are associated with a different cardiovascular profile. Diabetes Care 26:2318–2322
   PubMed Web of Science ®Google Scholar
• Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, Ballantyne CM. 2007. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care 30:325–331
   PubMed Web of Science ®Google Scholar
• Park C, Guallar E, Linton JA, Lee DC, Jang Y, Son DK, Han EJ, et al. 2013. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. Diabetes Care 36:1988–1993
   PubMed Web of Science ®Google Scholar
• Piche ME, Arcand-Bosse JF, Despres JP, Perusse L, Lemieux S, Weisnagel SJ. 2004. What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care 27:2470–2477
   PubMed Web of Science ®Google Scholar
• Shaw JE, Zimmet PZ, Hodge AM, De Courten M, Dowse GK, Chitson P, Tuomilehto J, Alberti KG. 2000. Impaired fasting glucose: how low should it go? Diabetes Care 23:34–39
   PubMed Web of Science ®Google Scholar
• Shaye K, Amir T, Shlomo S, Yechezkel S. 2012. Fasting glucose levels within the high normal range predict cardiovascular outcome. Am Heart J 164:111–116
   PubMed Web of Science ®Google Scholar
• Shin JY, Lee HR, Lee DC. 2011. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol 10:30
   PubMed Web of Science ®Google Scholar
• Tai ES, Goh SY, Lee JJ, Wong MS, Heng D, Hughes K, Chew SK, et al. 2004. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care 27:1728–1734
   PubMed Web of Science ®Google Scholar
• Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A. 2005. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353:454–462
   Google Scholar
• Vaccaro O, Riccardi G. 2005. Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition. Diabetes Care 28:1786–1768
   PubMed Web of Science ®Google Scholar
• Vasan RS. 2008. What is an abnormal blood glucose level? Combining lessons from epidemiology and in vivo plaque imaging. JACC Cardiovasc Imaging 1:46–48
   PubMed Web of Science ®Google Scholar